Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$907M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$644M |
| 4 |
NVIDIA
NVDA
|
+$440M |
| 5 |
CRH
CRH
|
+$429M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$689M |
| 2 |
Home Depot
HD
|
+$377M |
| 3 |
Cigna
CI
|
+$322M |
| 4 |
Valero Energy
VLO
|
+$250M |
| 5 |
Amphenol
APH
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.2% |
| 2 | Healthcare | 7.6% |
| 3 | Financials | 5.15% |
| 4 | Consumer Discretionary | 5.03% |
| 5 | Industrials | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
CALL
PNC Financial Services
PNC
$99.7B
| $5.77M | ﹤0.01% |
47,000
-38,700
| -45% | -$4.87M |
|
|
SEM
2502
DELISTED
Select Medical
SEM
| $5.77M | ﹤0.01% |
423,780
+235,491
| +125% | +$3.64M |
|
2503
CALL
Abercrombie & Fitch
ANF
$4.42B
| $5.76M | ﹤0.01% |
+102,200
| New | +$4.54M |
|
2504
PUT
TripAdvisor
TRIP
$1.65B
| $5.76M | ﹤0.01% |
347,400
+32,400
| +10% | +$529K |
|
2505
Conduent
CNDT
$244M
| $5.75M | ﹤0.01% |
1,653,730
+579,207
| +54% | +$1.93M |
|
2506
CALL
Akamai
AKAM
$16.7B
| $5.74M | ﹤0.01% |
53,900
-50,000
| -48% | -$4.98M |
|
2507
CALL
Stellantis
STLA
$21.7B
| $5.74M | ﹤0.01% |
300,100
-382,500
| -56% | -$7.16M |
|
|
SA
2508
Seabridge Gold
SA
$2.78B
| $5.74M | ﹤0.01% |
543,714
-363,027
| -40% | -$4.31M |
|
|
NOVA
2509
DELISTED
Sunnova Energy
NOVA
| $5.73M | ﹤0.01% |
547,485
+530,854
| +3,192% | +$8.3M |
|
2510
Vishay Precision Group
VPG
$1.22B
| $5.73M | ﹤0.01% |
170,637
-2,861
| -2% | -$102K |
|
2511
CALL
Corning
GLW
$119B
| $5.73M | ﹤0.01% |
187,900
+64,800
| +53% | +$2.12M |
|
|
BNY
2512
Bank of New York Mellon
BNY
$106B
| $5.72M | ﹤0.01% |
134,181
-2,427,944
| -95% | -$108M |
|
2513
News Corp Class A
NWSA
$14.9B
| $5.72M | ﹤0.01% |
285,264
-219,100
| -43% | -$4.44M |
|
2514
CALL
GSK
GSK
$104B
| $5.72M | ﹤0.01% |
157,800
-192,300
| -55% | -$6.83M |
|
2515
PUT
Colgate-Palmolive
CL
$73.1B
| $5.71M | ﹤0.01% |
80,300
-49,200
| -38% | -$3.68M |
|
2516
Grupo Cibest SA
CIB
$22B
| $5.7M | ﹤0.01% |
213,699
-230,123
| -52% | -$6.39M |
|
2517
Moderna
MRNA
$21.8B
| $5.69M | ﹤0.01% |
55,061
-105,902
| -66% | -$11.8M |
|
2518
CALL
Zions Bancorporation
ZION
$10.2B
| $5.69M | ﹤0.01% |
+163,000
| New | +$5.68M |
|
2519
IBM
IBM
$211B
| $5.69M | ﹤0.01% |
40,535
-341,665
| -89% | -$48.6M |
|
2520
Installed Building Products
IBP
$6.01B
| $5.68M | ﹤0.01% |
45,501
+21,852
| +92% | +$3.09M |
|
2521
Vistra
VST
$50B
| $5.68M | ﹤0.01% |
171,232
-2,509,330
| -94% | -$75.4M |
|
|
PNT
2522
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $5.68M | ﹤0.01% |
+851,735
| New | +$7.08M |
|
|
ESPR
2523
DELISTED
Esperion Therapeutics
ESPR
| $5.68M | ﹤0.01% |
5,794,029
+2,447,303
| +73% | +$3.54M |
|
2524
iHeartMedia
IHRT
$543M
| $5.68M | ﹤0.01% |
1,795,998
-119,001
| -6% | -$449K |
|
2525
Vertex
VERX
$2.09B
| $5.66M | ﹤0.01% |
244,927
-560,791
| -70% | -$11.5M |
|
Similar funds
Millennium Management's Q3 2023 Portfolio in Review
As of Q3 2023, Millennium Management held 6,895 positions worth $198B, down 2.3% from $203B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Millennium Management's Q3 2023 filing shows 836 new, 2,327 increased, 2,312 reduced and 834 closed positions. Its largest new stake was Mobileye: 2,953,164 shares worth $123M. The largest sale was iShares Core S&P 500 ETF, an estimated $689M.
By sector, the portfolio is most concentrated in Technology at 9.2% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Financials.
- Millennium Management's largest Q3 2023 buy was Mobileye: 2,953,164 shares worth $123M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.7B increase.
- Millennium Management's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $689M.
- Millennium Management fully exited Blackstone in Q3 2023, selling an estimated $178M.
- Millennium Management's ten largest holdings make up 21% of its $198B portfolio in Q3 2023.
- Millennium Management opened 836 new positions and closed 834 in Q3 2023.
- Millennium Management's portfolio value fell 2.3% quarter-over-quarter to $198B.
Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.